RedHill Biopharma Announces Exclusive U.S. CoPromotion Agreement with...
RedHill and Concordia entered into an exclusive copromotion agreement granting RedHill certain U.S. promotion rights for Donnatal DonnatalÂ1ÂTablets and Elixir syrupÂis a prescription oral drug used...
View ArticleRedHill Biopharma Announces Exclusive U.S. CoPromotion Agreement with...
RedHill and Concordia entered into an exclusive copromotion agreement granting RedHill certain U.S. promotion rights for Donnatal DonnatalÂ1 Tablets and Elixir syrup is a prescription oral drug used...
View ArticleRedHill Biopharma Announces Exercise of Underwriters' Option
TELAVIV Israel Jan. 03 2017 GLOBE NEWSWIRE RedHill Biopharma Ltd. NASDAQRDHL TASERDHL "RedHill" or the "Company" a specialty biopharmaceutical company primarily...
View ArticleArena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for...
SAN DIEGO Jan. 4 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced that it has amended its BELVIQÂ lorcaserin HCl marketing and supply agreement with Eisai Co. Ltd. and Eisai Inc....
View ArticleEnterome Starts Phase I Clinical Trial With its Lead Candidate EB8018 to...
PARIS and CAMBRIDGE Massachusetts January 5 2017 PRNewswire EB8018 is a firstinclass oral small molecule targeting the hostmicrobiome interaction by blocking FimH ENTEROME SA a pioneer in the...
View ArticleSoligenix Receives Positive Scientific Advice from the European Medicines...
PRINCETON N.J. Jan. 5 2017 PRNewswire Soligenix Inc. Nasdaq SNGX a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet...
View ArticleBuzzing the vagus nerve just right to fight inflammatory disease
Georgia Institute of Technology Electrical vagus nerve stimulation can help fight inflammatory diseases like Crohn's or arthritis but can also contribute somewhat to inflammation. Engineers have...
View ArticleKey Patent is Issued Covering Protagonist Therapeutics' Alpha4Beta7 Integrin...
MILPITAS Calif. Jan. 5 2017 PRNewswire Protagonist Therapeutics Inc. NASDAQ PTGX today announced that a key patent has issued covering orally stable peptides from the company's most advanced...
View ArticleNektar Therapeutics' President and CEO Howard W. Robin To Present at the 35th...
SAN FRANCISCO Jan. 5 2017 PRNewswire Nektar Therapeutics' Nasdaq NKTR President and Chief Executive Officer Howard W. Robin is scheduled to present at the upcoming 35th Annual J.P. Morgan Healthcare...
View ArticleSoligenix Inc SNGX Pharmaceuticals Healthcare Deals and Alliances Profile...
SummarySoligenix Inc Soligenix is a latestage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures....
View ArticleSoligenix to Present at 9th Annual Biotech Showcase Conference
PRINCETON N.J. Jan. 6 2017 PRNewswire Soligenix Inc. Nasdaq SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases...
View ArticleEnterome initiates Phase I study of EB8018 to treat Crohn's disease
French pharmaceuticals and diagnostics company Enterome has initiated its Phase I clinical study of EB8018 to treat Crohn's disease.
View ArticleAmidst Affordable Care Act Repeal Efforts Crohn's & Colitis Foundation of...
NEW YORK Jan. 6 2017 PRNewswireUSNewswire The Crohn's & Colitis Foundation of America CCFA released the following statement today urging Congress to maintain stability in insurance coverage for...
View ArticleRedHill Biopharma Announces YELIVAÂ ABC294640 Abstract Presentation at the...
The abstract to be presented at the upcoming 2017 Cholangiocarcinoma Foundation Annual Conference describes positive findings from nonclinical studies and the Phase I clinical study with...
View ArticleRedHill Biopharma Ltd RDHL Pharmaceuticals Healthcare Deals and Alliances...
SummaryRedHill Biopharma Ltd RedHill is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs for the treatment of inflammatory and gastrointestinal...
View ArticleCrohn's Colitis Foundation of America Pharmaceuticals Healthcare Deals and...
SummaryCrohn's Colitis Foundation of America CCFA is a healthcare foundation which offers treatment for crohn's disease and ulcerative colitis. The foundation funds cuttingedge studies at medical...
View ArticleChemoCentryx Inc CCXI Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryChemoCentryx Inc ChemoCentryx discovers develops and commercializes orallyadministered therapeutics for the treatment of cancer autoimmune diseases and inflammatory disorders with major focus on...
View ArticleImmune Pharmaceuticals Inc IMNP Pharmaceuticals Healthcare Deals and...
SummaryImmune Pharmaceuticals Inc Immune Pharma formerly EpiCept Corporation is a pharmaceutical company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and...
View ArticleGalapagos NV GLPG Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryGalapagos NV Galapagos is a clinical stage biotechnology company that discovers and develops pharmaceutical products. The company's product pipeline encompasses investigational candidates...
View Article